Literature DB >> 18372919

Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.

L De Boer1, V Oakes, H Beamish, N Giles, F Stevens, M Somodevilla-Torres, C Desouza, B Gabrielli.   

Abstract

Cyclin A/cdk2 has a role in progression through S phase, and a large pool is also activated in G2 phase. Here we report that this G2 phase pool regulates the timing of progression into mitosis. Knock down of cyclin A by siRNA or addition of a specific cdk2 small molecule inhibitor delayed entry into mitosis by delaying cells in G2 phase. The G2 phase-delayed cells contained elevated levels of inactive cyclin B/cdk1. However, increased microtubule nucleation at the centrosomes was observed, and the centrosomes stained for markers of cyclin B/cdk1 activity. Both microtubule nucleation at the centrosomes and the phosphoprotein markers were lost with short-term treatment of the cdk1/2 inhibitor roscovitine but not the Mek1/2 inhibitor U0126. Cyclin A/cdk2 localized at the centrosomes in late G2 phase after separation of the centrosomes but before the start of prophase. Thus G2 phase cyclin A/cdk2 controls the timing of entry into mitosis by controlling the subsequent activation of cyclin B/cdk1, but also has an unexpected role in coordinating the activation of cyclin B/cdk1 at the centrosome and in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372919     DOI: 10.1038/onc.2008.74

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates.

Authors:  Meritxell Orpinell; Marjorie Fournier; Anne Riss; Zita Nagy; Arnaud R Krebs; Mattia Frontini; Làszlò Tora
Journal:  EMBO J       Date:  2010-06-18       Impact factor: 11.598

2.  IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes.

Authors:  W-L Hsieh; Y-H Huang; T-M Wang; Y-C Ming; C-N Tsai; J-H S Pang
Journal:  Cell Prolif       Date:  2015-02-09       Impact factor: 6.831

Review 3.  Safeguarding entry into mitosis: the antephase checkpoint.

Authors:  Cheen Fei Chin; Foong May Yeong
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

4.  Quantitative reconstitution of mitotic CDK1 activation in somatic cell extracts.

Authors:  Richard W Deibler; Marc W Kirschner
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

5.  Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding.

Authors:  Gaetan Pascreau; Frank Eckerdt; Mair E A Churchill; James L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

6.  Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.

Authors:  Vanessa Oakes; Weili Wang; Brittney Harrington; Won Jae Lee; Heather Beamish; Kee Ming Chia; Alex Pinder; Hidemasa Goto; Masaki Inagaki; Sandra Pavey; Brian Gabrielli
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

8.  Cdk2 is required for p53-independent G2/M checkpoint control.

Authors:  Jon H Chung; Fred Bunz
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

Review 9.  The decision to enter mitosis: feedback and redundancy in the mitotic entry network.

Authors:  Arne Lindqvist; Verónica Rodríguez-Bravo; René H Medema
Journal:  J Cell Biol       Date:  2009-04-13       Impact factor: 10.539

10.  Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation.

Authors:  Roberta Alfieri; Matteo Barberis; Ferdinando Chiaradonna; Daniela Gaglio; Luciano Milanesi; Marco Vanoni; Edda Klipp; Lilia Alberghina
Journal:  BMC Bioinformatics       Date:  2009-10-15       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.